Capex / revenue moved 302 bp lower
Capex / revenue changed -302 basis points from the comparable as-filed period.
3.62%→0.60%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →VRA financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure decreased 82.2%
Capital expenditure changed -82.2% from the comparable as-filed period. The change ranks at the 67th percentile of 6 prior comparable changes.
$1.9M→$333,0006 prior comparisons
Free-cash-flow proxy increased 71.8%
Free-cash-flow proxy changed +71.8% from the comparable as-filed period. The change ranks at the 83th percentile of 6 prior comparable changes.
-$19.8M→-$5.6M6 prior comparisons
Gross margin moved 768 bp higher
Gross margin changed +768 basis points from the comparable as-filed period.
44.08%→51.76%3 prior comparisons
Gross profit increased 26.6%
Gross profit changed +26.6% from the comparable as-filed period.
$22.8M→$28.8M3 prior comparisons
Inventory decreased 26.4%
Inventory changed -26.4% from the comparable as-filed period.
$99.2M→$73.0M3 prior comparisons
Net income increased 85.6%
Net income changed +85.6% from the comparable as-filed period.
-$33.5M→-$4.8M2 prior comparisons
Operating cash flow increased 70.7%
Operating cash flow changed +70.7% from the comparable as-filed period. The change ranks at the 83th percentile of 6 prior comparable changes.
-$17.9M→-$5.3M6 prior comparisons
Operating income increased 74.0%
Operating income changed +74.0% from the comparable as-filed period.
-$17.9M→-$4.6M3 prior comparisons
Operating margin moved 2623 bp higher
Operating margin changed +2623 basis points from the comparable as-filed period.
-34.57%→-8.34%3 prior comparisons
Stock-based compensation increased 33.3%
Stock-based compensation changed +33.3% from the comparable as-filed period. The change ranks at the 83th percentile of 6 prior comparable changes.
$754,000→$1.0M6 prior comparisons
Selling, general & administrative decreased 16.4%
Selling, general & administrative changed -16.4% from the comparable as-filed period.
$40.8M→$34.1M3 prior comparisons
Cash & equivalents increased 10.9%
Cash & equivalents changed +10.9% from the comparable as-filed period.
$11.3M→$12.5M2 prior comparisons
Revenue increased 7.8%
Revenue changed +7.8% from the comparable as-filed period.
$51.7M→$55.7M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.